Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 23, 2015
Physiologically based pharmacokinetic modeling for sequential metabolism: effect of CYP2C19 genetic polymorphism on clopidogrel and clopidogrel active metabolite pharmacokineticsNassim Djebli, David Fabre, Xavier Boulenc, et al.Scandinavian Journal of Infectious Diseases|February 13, 2003
Lack of effect of food on the bioavailability of a new ketolide antibacterial, telithromycinVijay Bhargava, Bernard Lenfant, Catherine Perret, et al.Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|September 4, 2008
Coherent structures in dissipative particle dynamics simulations of the transition to turbulence in compressible shear flowsJan-Willem van de Meent, Alexander Morozov, Ellák Somfai, et al.Clinical Drug Investigation|December 18, 2025
Unexpected Clinical Drug-Drug Interaction of Fexinidazole on Midazolam Pharmacokinetics: Insights into Underlying Mechanisms from Clinical Phase I Study Results and Supporting In Vivo/Vitro EvidenceMatthieu Gassiot, Priscilla Brun, Valerie Wauthier, et al.Drug Development and Industrial Pharmacy|June 2, 2020
Long-term stability of insulin glulisine loaded nanoparticles formulated using an amphiphilic cyclodextrin and designed for intestinal deliveryElena Presas, Eric Sultan, Valeria Gervasi, et al.Journal of Clinical Pharmacology|December 1, 2011
Clopidogrel pharmacodynamics and pharmacokinetics in the fed and fasted state: a randomized crossover study of healthy menFabrice Hurbin, Xavier Boulenc, Nikki Daskalakis, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 4, 2018
Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulinElena Presas, Fiona McCartney, Eric Sultan, et al.Thrombosis and Haemostasis|February 9, 2011
An improved method for specific and quantitative determination of the clopidogrel active metabolite isomers in human plasmaGilles Tuffal, Sebastien Roy, Melanie Lavisse, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
SAR110894, a potent histamine H3-receptor antagonist, displays disease-modifying activity in a transgenic mouse model of tauopathyPhilippe Delay-Goyet, Véronique Blanchard, Nathalie Schussler, et al.Pageof 1